Surgical fix offers new hope for failed emphysema treatment

NCT ID NCT05257681

First seen Jun 27, 2026 ยท Last updated Jun 27, 2026

Summary

This pilot study tests a surgical procedure for people with severe emphysema or COPD who did not get enough benefit from a standard treatment using bronchoscopic lung volume reduction (valves). The surgery uses small chest incisions to complete the fissures between lung lobes and remove scar tissue, aiming to reduce air trapping and improve breathing. Up to 20 participants aged 40 to 75 will be enrolled to see if the procedure is feasible and safe.

What this could mean

Our plain-language read of the trial. This is informational only โ€” not medical advice or a prediction.

Active substance
surgical procedure (video-assisted thoracoscopic surgery or robotic stapling to complete lung fissures and remove adhesions)
What this could lead to
If it works, this could offer a second chance for emphysema patients who didn't benefit from a less invasive valve procedure, potentially improving breathing and quality of life.
What could go wrong
This is a very small, early pilot study with only 20 people. The surgery is invasive and carries risks like infection, bleeding, or complications that could outweigh benefits. Success is not guaranteed.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for EMPHYSEMA OR COPD are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Beth Israel Deaconess Medical Center

    RECRUITING

    Boston, Massachusetts, 02215, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.